Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06. - Wikidata - wikimedia - TriplyDB

Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.

Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.

http://www.wikidata.org/entity/Q34161145

about

Proton therapy for early stage prostate cancer: is there a case?Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort.Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.Proctitis following stereotactic body radiation therapy for prostate cancer Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?Clinical implementation of a knowledge based planning tool for prostate VMAT.Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer.Preliminary analysis of risk factors for late rectal toxicity after helical tomotherapy for prostate cancer.Vision 20/20: Automation and advanced computing in clinical radiation oncology.A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.Considerations for using data envelopment analysis for the assessment of radiotherapy treatment plan quality.

P2860

Q28072657-E5B5D3A3-4A35-4E2A-9736-FABDA0085408 Q30664267-5B44E7FF-8197-40C9-957C-B4FB8AC17AA6 Q33919002-5BC884D2-20E8-4136-A4BA-4D54DF0A71C0 Q34748877-38C74048-7F4E-4805-97E8-51DD21DE2817 Q35607117-1D5BE4A9-CDE5-4858-9CCB-1A5ACF517B41 Q37110245-D3A94968-8EEC-4943-BA8B-4C82DB727770 Q37139334-AB13F2B5-D91B-4E10-A96A-65CCCCD60F0B Q38095001-ACF281D1-D795-463B-854C-15BBF36475A8 Q38797630-F9ACEFAB-25DC-4EE6-BE1C-39B1CD6B195E Q39375431-E1209002-7C15-48F2-83C0-6FF328FEFC6B Q41955928-1225C6A2-F506-4AA7-8D17-5CFDA0B39D4E Q42635816-6B132939-A32D-4485-A961-F9B7D91081FC Q45038563-71DADB0C-ACBA-4583-8DD9-025679DBA676 Q47674690-044DBA05-10DD-4CF7-A3AF-33BECEF906C5

P2860

Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.

http://www.wikidata.org/entity/Q34161145

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Do intermediate radiation dose ...... oncology group protocol 94-06.

@ast

Do intermediate radiation dose ...... oncology group protocol 94-06.

@en

Do intermediate radiation dose ...... oncology group protocol 94-06.

@nl

type

label

Do intermediate radiation dose ...... oncology group protocol 94-06.

@ast

Do intermediate radiation dose ...... oncology group protocol 94-06.

@en

Do intermediate radiation dose ...... oncology group protocol 94-06.

@nl

prefLabel

Do intermediate radiation dose ...... oncology group protocol 94-06.

@ast

Do intermediate radiation dose ...... oncology group protocol 94-06.

@en

Do intermediate radiation dose ...... oncology group protocol 94-06.

@nl

P1433

Q34161145-971729EE-48DC-4196-AD3A-5C20FF5A3043

P1476

Q34161145-D23CD8B2-82DE-4D0C-AF7E-27B238AB4E99

P2093

Q34161145-2AC9E074-60F1-4910-B99D-D0E27EB8241D

Q34161145-2EFAA030-221F-4BD2-AE53-C1E24B65686A

Q34161145-323A22D6-2166-420B-810C-EF3B598A4DBF

Q34161145-75AFDBAA-0CDC-44F2-9981-B3CF20C9A0A1

Q34161145-E5127850-DD7F-42F4-9727-5345035BA0D1

Q34161145-F00FF6A3-659A-4FE2-9F48-F781540A4D10

P2860

Q34161145-1589BC08-BD71-4B26-A0AC-B95221D5EBA6

Q34161145-32AB0B89-BB2E-44CA-B00A-FBDE434E3555

Q34161145-6074B966-D73D-4004-9002-E77ACFB6C006

Q34161145-66EC60EE-0D5C-4FFE-BAFC-3A2231E5388A

Q34161145-72BC0878-FC31-453C-B048-5C77046705F6

Q34161145-816D0C90-9DAC-46F6-96AE-8C85A1A10AA7

Q34161145-83DAF01F-DB13-4800-9F2D-19724044D160

Q34161145-845B37FF-72F3-4711-9743-0A74FA8843F1

Q34161145-9D4B2DBF-76B7-4E97-A187-A7721E78C4AF

Q34161145-CA3EB023-E920-453F-87CA-EA684B4C6CB2

P304

Q34161145-159CAC7B-7970-4F1F-BB49-5407CF896543

P31

Q34161145-786E7D48-5D30-4719-A371-29C7B96AC51B

P356

Q34161145-9786DB78-E7C3-4BDE-B5E2-E8ECB6107C65

P407

Q34161145-9DEA85A6-AF3C-430F-9C09-AC0FD230DC6A

P433

Q34161145-1F9AF9E7-DEAD-492F-A654-E593D978A5D8

P478

Q34161145-E2CDD571-83BD-4E87-9BB6-8ADEAFE0C066

P50

Q34161145-1FEE2D08-FD7F-4F55-B874-BB91D5639B9D

Q34161145-A052FD0A-5793-4426-9B64-7CE7A64222CE

P577

Q34161145-DD203311-8B92-47A0-8B93-2527D23CDB80

P698

Q34161145-C51591BD-D9F2-4AAE-9A54-A3AC57CB4767

P921

Q34161145-7CCC669E-BBBC-4E5C-81CD-F88456963429

P932

Q34161145-722B2027-949D-4A14-A944-DEDCCA7F94DF

P356

J.IJROBP.2011.11.073

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Do intermediate radiation dose ...... oncology group protocol 94-06.

@en

P2093

James A Purdy

http://www.w3.org/2001/XMLSchema#string

James D Cox

http://www.w3.org/2001/XMLSchema#string

Jeff M Michalski

http://www.w3.org/2001/XMLSchema#string

Kathryn Winter

http://www.w3.org/2001/XMLSchema#string

Susan L Tucker

http://www.w3.org/2001/XMLSchema#string

Walter R Bosch

http://www.w3.org/2001/XMLSchema#string

P2860

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model

Radiation dose-volume effects in radiation-induced rectal injury.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.

Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.

Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer.

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

P304

390-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2011.11.073

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22342302

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3952553

http://www.w3.org/2001/XMLSchema#string